Contact Us
  Search
The Business Research Company Logo

Home Spirometry App Market Report 2026

Buy Now
Global Home Spirometry App Market Report 2026
Published :January 2026
Pages :150
Format :PDF
Delivery Time :2-3 Business Days
Why 2-3 days? We update the report with the latest data and news before delivery. Let us know if you need us to expedite.
Report Price :$4,490.00

Home Spirometry App Market Report 2026

Global Outlook – By Product Type (Standalone Apps, Integrated Apps), By Platform (iPhone Operating System (iOS), Android, Windows, Other Platforms), By Distribution Channel (App Stores, Direct Sales, Healthcare Facilities, Other Distribution Channels), By Application (Chronic Obstructive Pulmonary Disease (COPD), Asthma, Cystic Fibrosis, Pulmonary Fibrosis, Other Applications), By End-User (Patients, Healthcare Providers, Research Institutes, Other End-Users) - Market Size, Trends, And Global Forecast 2026-2035

Home Spirometry App Market Overview

• Home Spirometry App market size has reached to $1.13 billion in 2025 • Expected to grow to $2.36 billion in 2030 at a compound annual growth rate (CAGR) of 15.8% • Growth Driver: Increasing Prevalence Of Respiratory Diseases Driving The Market Growth Due To Rising Demand For Remote Lung Function Monitoring • Market Trend: Advancing Remote Cardiopulmonary Monitoring For Personalized Respiratory Care • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.
Research Expert

Book your 30 minutes free consultation with our research experts

What Is Covered Under Home Spirometry App Market?

A home spirometry app is a digital tool designed to measure and track lung function remotely. It connects with spirometry devices to record detailed respiratory metrics such as forced expiratory volume, forced vital capacity, and peak expiratory flow, providing precise data on lung performance. The app securely stores, organizes, and visualizes respiratory data over time, enabling trends and patterns to be analyzed to support ongoing monitoring, early detection of changes, and management of pulmonary health. The main product types of home spirometry apps are standalone apps and integrated apps. A standalone app refers to a self-sufficient software application that operates independently on a device without needing external systems or internet connectivity to perform its core functions. These apps are integrated across various platforms such as iPhone operating system (iOS), Android, Windows, and other platforms, and are distributed through app stores, direct sales, healthcare facilities, and other distribution channels. They are used for various applications including chronic obstructive pulmonary disease (COPD), asthma, cystic fibrosis, pulmonary fibrosis, and other respiratory conditions, and are used by various end-users such as patients, healthcare providers, and research institutes.
Home Spirometry App Market Global Report 2026 Market Report bar graph

What Is The Home Spirometry App Market Size and Share 2026?

The home spirometry app market size has grown rapidly in recent years. It will grow from $1.13 billion in 2025 to $1.31 billion in 2026 at a compound annual growth rate (CAGR) of 16.1%. The growth in the historic period can be attributed to increasing prevalence of chronic respiratory diseases, expansion of home-based healthcare monitoring, rising adoption of connected medical devices, improved accuracy of portable spirometers, growing acceptance of remote patient monitoring.

What Is The Home Spirometry App Market Growth Forecast?

The home spirometry app market size is expected to see rapid growth in the next few years. It will grow to $2.36 billion in 2030 at a compound annual growth rate (CAGR) of 15.8%. The growth in the forecast period can be attributed to increasing demand for chronic disease management tools, rising integration with electronic health records, expansion of ai-assisted respiratory analytics, growing use in post-acute care monitoring, increasing adoption of virtual pulmonary care models. Major trends in the forecast period include increasing adoption of remote lung function monitoring, rising integration with smart spirometry devices, growing use of longitudinal respiratory data analytics, expansion of telehealth-compatible spirometry platforms, enhanced focus on clinical-grade measurement accuracy.

Global Home Spirometry App Market Segmentation

1) By Product Type: Standalone Apps, Integrated Apps 2) By Platform: iPhone Operating System (iOS), Android, Windows, Other Platforms 3) By Distribution Channel: App Stores, Direct Sales, Healthcare Facilities, Other Distribution Channels 4) By Application: Chronic Obstructive Pulmonary Disease (COPD), Asthma, Cystic Fibrosis, Pulmonary Fibrosis, Other Applications 5) By End-User: Patients, Healthcare Providers, Research Institutes, Other End-Users Subsegments: 1) By Standalone Apps: Smartphone-Based Standalone Spirometry Apps, Tablet-Based Standalone Spirometry Apps, Desktop-Based Standalone Spirometry Apps, Cloud-Connected Standalone Spirometry Apps 2) By Integrated Apps: Smart Spirometer-Integrated Apps, Wearable Device-Integrated Apps, Electronic Health Record (EHR)-Integrated Apps, Telehealth Platform-Integrated Apps

What Is The Driver Of The Home Spirometry App Market?

The increasing prevalence of respiratory diseases is expected to propel the growth of the home spirometry app market going forward. Respiratory diseases refer to medical conditions that affect the lungs and airways, making it difficult to breathe and causing symptoms such as coughing, wheezing, shortness of breath, and chest discomfort. The prevalence of respiratory diseases is rising due to the aging population, which is more susceptible to chronic lung conditions, and increasing exposure to air pollution that worsens respiratory health. Home spirometry app supports the management of respiratory diseases by enabling patients to regularly monitor their lung function from home, track symptoms over time, detect early signs of deterioration, and share real-time data with healthcare providers for timely interventions, ultimately helping to maintain better respiratory health and prevent complications. For instance, in October 2024, according to the National Asthma Council, an Australia-based non-profit organization, in 2023, Australia recorded a total of 474 asthma-related deaths, comprising 325 females and 149 males. This figure is almost identical to the 473 asthma-related deaths reported in 2022, highlighting a consistent trend in asthma mortality over the two years. Therefore, the increasing prevalence of respiratory diseases is driving the growth of the home spirometry app industry.

Key Players In The Global Home Spirometry App Market

Major companies operating in the home spirometry app market are Cipla Limited, Clario Inc., Contec Medical Systems Co. Ltd., Vitalograph Ltd., NDD Medical Technologies AG, CareSimple Inc., MediTuner AB, NuvoAir AB, Monitored Therapeutics Inc., Sibelmed S.A., ZEPHYRx LLC, Alveofit Technologies Pvt. Ltd., Spiromagic ApS, Respirit Healthcare Pvt. Ltd., patientMpower Ltd., CMI Health Inc. (SpiroLink), Smart Respiratory Products Ltd., Koneksa Health Inc., AioCare Sp. z o.o., VitalFlo Inc.

What Are Latest Mergers And Acquisitions In The Home Spirometry App Market?

In May 2025, Huma Therapeutics Limited, a UK-based health technology company, acquired Aluna, Inc. for an undisclosed amount. With this acquisition, Huma aims to expand its respiratory health capabilities by integrating Aluna’s AI-powered remote monitoring solutions and proprietary spirometers into the Huma Cloud Platform, creating a comprehensive digital health ecosystem that enhances chronic respiratory care for patients, providers, and health systems worldwide. Aluna Inc. is a US-based technology company that specializes in providing a home spirometry application for remote monitoring of respiratory health.

Regional Outlook

North America was the largest region in the home spirometry app market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Need data on a specific region in this market?

What Defines the Home Spirometry App Market?

The home spirometry app market consists of revenues earned by entities by providing services such as telehealth integration, personalized health coaching, data storage and trend tracking, software development kits (SDKs) medication adherence tracking, patient education and training, clinical trial support, predictive analytics, multi-device connectivity, insurance and reimbursement support, professional dashboards for healthcare providers, and regulatory compliance and data security services. The market value includes the value of related goods sold by the service provider or included within the service offering. The home spirometry app market also includes sales of accessories and supporting tools, digital home spirometers, remote monitoring and telehealth platforms. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Home Spirometry App Market Report 2026?

The home spirometry app market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the home spirometry app industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Home Spirometry App Market Report Forecast Analysis

Report Attribute Details
Market Size Value In 2026$1.31 billion
Revenue Forecast In 2035$2.36 billion
Growth RateCAGR of 16.1% from 2026 to 2035
Base Year For Estimation2025
Actual Estimates/Historical Data2020-2025
Forecast Period2026 - 2030 - 2035
Market RepresentationRevenue in USD Billion and CAGR from 2026 to 2035
Segments CoveredProduct Type, Platform, Distribution Channel, Application, End-User
Regional ScopeAsia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country ScopeThe countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies ProfiledCipla Limited, Clario Inc., Contec Medical Systems Co. Ltd., Vitalograph Ltd., NDD Medical Technologies AG, CareSimple Inc., MediTuner AB, NuvoAir AB, Monitored Therapeutics Inc., Sibelmed S.A., ZEPHYRx LLC, Alveofit Technologies Pvt. Ltd., Spiromagic ApS, Respirit Healthcare Pvt. Ltd., patientMpower Ltd., CMI Health Inc. (SpiroLink), Smart Respiratory Products Ltd., Koneksa Health Inc., AioCare Sp. z o.o., VitalFlo Inc.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Frequently Asked Questions

The Home Spirometry App market was valued at $1.13 billion in 2025, increased to $1.31 billion in 2026, and is projected to reach $2.36 billion by 2030.
request a sample here
The global Home Spirometry App market is expected to grow at a CAGR of 15.8% from 2026 to 2035 to reach $2.36 billion by 2035.
request a sample here
Some Key Players in the Home Spirometry App market Include, Cipla Limited, Clario Inc., Contec Medical Systems Co. Ltd., Vitalograph Ltd., NDD Medical Technologies AG, CareSimple Inc., MediTuner AB, NuvoAir AB, Monitored Therapeutics Inc., Sibelmed S.A., ZEPHYRx LLC, Alveofit Technologies Pvt. Ltd., Spiromagic ApS, Respirit Healthcare Pvt. Ltd., patientMpower Ltd., CMI Health Inc. (SpiroLink), Smart Respiratory Products Ltd., Koneksa Health Inc., AioCare Sp. z o.o., VitalFlo Inc. .
request a sample here
Major trend in this market includes: Advancing Remote Cardiopulmonary Monitoring For Personalized Respiratory Care. For further insights on this market.
request a sample here
North America was the largest region in the home spirometry app market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the home spirometry app market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
request a sample here
Research Expert

Book your 30 minutes free consultation with our research experts

Chat with us